In conclusion, these data demonstrate that all VSV-GP variants can bind to heparin and that low affinity VSV-GP variants efficiently use HSPG for virus attachment but not entry in Burkitt Lymphoma cell lines BJAB and Raji. The gene discussed is HSPG2; the disease is Burkitt lymphoma.